Skip to main content
Caplight Logo









Angstrom Bio, Inc.

Angstrom Bio, Inc.

Private
Austin, TexasHealthcare & Life Scienceshttps://angstrom.bio/

Last Round

VC Round

Jun 16, 2021

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Angstrom Bio, Inc. is a biotechnology company that develops a sequencing-based molecular diagnostics platform using nanopore sequencing and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

molecular diagnosticsnanopore sequencingrespiratory pathogen detectionhigh-throughput testingviral variant detectionNGSclinical diagnosticsnext-gen sequencingmedical AIcomputational biologyAI diagnosticsprecision medicinediagnostic platformpathogen surveillancebiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Angstrom Bio, Inc. Comparables

Compare Angstrom Bio, Inc. with similar companies based on industry and business-model similarity.

Angstrom Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neomend
70%
bioMérieux
65%
Karius
64%

Angstrom Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 16, 2021

Key People

Founding team and executive leadership

David States

Co-Founder and Chief Medical Officer

Founding Team

Angstrom Bio, Inc. Investors

Notable investors and investment history

Angstrom Bio, Inc. investors
InvestorRounds
GreyBird VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 51% MoM, reaching 2.9K.

  • Jul 29, 2026

    Monthly visitors increased 586% MoM.

Angstrom Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Angstrom Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Angstrom Bio, Inc.'s valuation, stock price, and market status.

Is Angstrom Bio, Inc. a public or private company?

Angstrom Bio, Inc. is a private company.

What is the current stock price of Angstrom Bio, Inc.?

Angstrom Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Angstrom Bio, Inc. worth (valuation)?

Valuation information for Angstrom Bio, Inc. is not publicly available.

Can I buy Angstrom Bio, Inc. stock?

Angstrom Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Angstrom Bio, Inc.'s last funding round?

Angstrom Bio, Inc.'s most recent funding round was Early Funding on June 16, 2021.

Who are the main investors in Angstrom Bio, Inc.?

Key investors in Angstrom Bio, Inc. include GreyBird Ventures.

Will Angstrom Bio, Inc. IPO soon?

No public IPO plans have been announced for Angstrom Bio, Inc..

How can I track Angstrom Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Angstrom Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustin, Texas
Employee Range2
Year Founded2019
Last FundingJun 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?